Pharmasset, Inc. HomepageSitemapContact Us
About Pharmasset Therapeutic Areas Our Product Candidates Investor Center Careers Contact Us
www.Pharmasset.com July 29, 2010 07:41 PM

Investor Relations

Press Releases

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Investor FAQs

Contact Us

Shareholder Tools

Email Alerts


Search Investor Relations



Press Releases

All Releases
View Summary Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C
Jul 28, 2010
PDF 13.3 KB Add to Briefcase
View Summary Pharmasset Announces Submission of Abstracts to AASLD Liver Meeting Including an Interim Analysis of Roche's Phase 2b PROPEL Trial of RG7128
Jun 9, 2010
PDF 13.7 KB Add to Briefcase
View Summary Pharmasset to Present at Two Upcoming Investor Conferences
Jun 7, 2010
PDF 11.4 KB Add to Briefcase
View Summary Pharmasset to Present at the Citi Global Healthcare Conference
May 20, 2010
PDF 11.2 KB Add to Briefcase
View Summary Pharmasset Announces Exercise of Underwriters' Overallotment Option
May 18, 2010
PDF 9.6 KB Add to Briefcase
View Summary Pharmasset Prices Public Offering of Common Stock
May 13, 2010
PDF 9.7 KB Add to Briefcase
View Summary Pharmasset Announces Proposed Public Offering of Common Stock
May 11, 2010
PDF 10.3 KB Add to Briefcase
View Summary Pharmasset Reports Fiscal Second Quarter 2010 Financial Results
May 5, 2010
PDF 18.7 KB Add to Briefcase
View Summary Pharmasset Affirms Safety and Continued Progress in Clinical Development of RG7128
May 4, 2010
PDF 11.1 KB Add to Briefcase
View Summary Pharmasset Announces Results of a 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepatitis C Infection
May 4, 2010
PDF 15.8 KB Add to Briefcase
View Summary Pharmasset to Present at the Bank of America Merrill Lynch Health Care Conference
Apr 30, 2010
PDF 11.0 KB Add to Briefcase
View Summary Pharmasset Announces Interim Data from an Ongoing 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepatitis C Infection
Apr 15, 2010
PDF 11.9 KB Add to Briefcase
View Summary Pharmasset to Present New Data on RG7128 and PSI-7977 at the EASL Conference
Apr 13, 2010
PDF 11.7 KB Add to Briefcase
View Summary Pharmasset Initiates First Time in Human Study of PSI-938 for the Treatment of Hepatitis C
Apr 8, 2010
PDF 11.2 KB Add to Briefcase
View Summary Pharmasset to Present at the Canaccord Adams Hepatitis C Conference
Mar 29, 2010
PDF 11.1 KB Add to Briefcase
View Summary Pharmasset to Present at Cowen and Company 30th Annual Healthcare Conference
Mar 3, 2010
PDF 12.2 KB Add to Briefcase
View Summary Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study
Feb 17, 2010
PDF 11.5 KB Add to Briefcase
View Summary Pharmasset Reports Fiscal First Quarter 2010 Financial Results
Feb 9, 2010
PDF 15.9 KB Add to Briefcase
View Summary Pharmasset Announces Exercise of Underwriter's Option
Jan 29, 2010
PDF 9.4 KB Add to Briefcase
View Summary Pharmasset Prices Underwritten Offering of Common Stock
Jan 28, 2010
PDF 9.5 KB Add to Briefcase
Showing 1-20 of 154 Page: 1 2 3 ... 8  Next 20
= add release to Briefcase
Pharmasset, Inc. Pharmasset, Inc. © 2010 . All Rights Reserved | Home | Top Return to Top
Site Design by Lakeshore Concepts